| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $19.45M | $16.01M | $9.33M | $8.04M | $4.60M |
| R&D | $17.22M | $12.95M | $7.70M | $6.48M | $3.56M |
| SG&A | $2.23M | $3.06M | $1.63M | $1.56M | $1.04M |
| Operating Income | -$19.45M | -$16.01M | -$9.33M | -$8.04M | -$4.60M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$19.36M | -$15.79M | -$8.89M | -$7.83M | -$4.57M |
| EPS (basic) | -1.4300 | -1.2100 | -0.6900 | -0.6100 | -0.3500 |
| EPS (diluted) | -1.4300 | -1.2100 | -0.6900 | -0.6100 | – |
| Shares (diluted) | $13.53M | $13.01M | $12.85M | $12.91M | – |